Northwest Biotherapeutics reported 638.8M in Market Capitalization this August of 2022, considering the latest stock price and the number of outstanding shares.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Market Capitalization Change
Agenus AGEN:US $ 0.52B 0.11B
Applied Genetic Technologies AGTC:US $ 0.05B 0.03B
AstraZeneca AZN:LN 167.34B 10.35B
Bristol Myers Squibb BMY:US $ 163.94B 8.45B
Celldex Therapeutics CLDX:US $ 1.26B 0.33B
Cti Biopharma CTIC:US $ 0.65B 0.18B
Cytori Therapeutics CYTX:US $ 0.01B 0.01B
Cytrx CYTR:US 0.01B 0.01B
Eisai 4523:JP 1697.85B 16.31B
Genocea Biosciences GNCA:US $ 0.07B 0.01B
Infinity Pharmaceuticals INFI:US $ 0.06B 0.05B
Merk MRK:US $ 230.55B 23.1B
Mirati Therapeutics MRTX:US $ 3.73B 0.84B
Northwest Biotherapeutics NWBO:US 0.67B 0.02B
Pfizer PFE:US $ 294.18B 1.79B
Roche Holding ROG:VX 300.5B 1.25B